Global blockchain supervision and query platform

English
Download

Crypto Biz: From banks to biotechs, real-world assets move onchain

Crypto Biz: From banks to biotechs, real-world assets move onchain WikiBit 2025-10-03 04:30

SoftBank and ARK reportedly circle Tether‘s $20 billion round; SEC weighs onchain stock trading; QNB taps JPMorgan’s Kinexys; Predictive Oncology embraces DePIN.

TradFi dives deeper into crypto: Tethers mega raise, SEC eyes onchain stocks, JPMorgan expands Kinexys and a biotech bets treasury on DePIN.

If this week‘s Crypto Biz had a theme, it’s the steady march of traditional finance deeper into cryptos core infrastructure.

Tether is reportedly courting major venture firms for a funding round that could value the stablecoin issuer alongside private tech giants like OpenAI. At the same time, US regulators are considering whether traditional stocks should trade onchain, as the convergence between the Securities and Exchange Commission, Wall Street and tokenization gains momentum.

Elsewhere, JPMorgans Kinexys platform added a major Gulf bank as a user, while a Nasdaq-listed biotech firm built a treasury entirely around a DePIN token.

SoftBank, ARK reportedly eye investment in Tethers mega funding round

High-profile investors are reportedly in talks to back Tethers upcoming funding round, which could value the stablecoin issuer at up to $500 billion, according to Bloomberg.

Venture capital firms SoftBank Group and ARK Investment Management are among those considering participation in a potential $20-billion raise. If completed, the round would place Tethers valuation on par with that of major private firms such as OpenAI.

Tether CEO Paolo Ardoino confirmed that the company is exploring a raise from “a select group of high-profile investors,” though he did not provide details on the deals structure.

Tether, issuer of the worlds largest stablecoin USDt (USDT), is among the most profitable companies globally on a per-employee basis. The firm has been expanding beyond its core stablecoin operations into areas such as infrastructure, energy production and venture capital investments as it diversifies revenue sources beyond interest income.

Source: Paolo ArdoinoSEC considers allowing stocks to trade onchain

In line with its recent recognition of tokenization as an “innovation,” the US Securities and Exchange Commission is reportedly exploring a plan that would allow US stocks to trade onchain via approved crypto exchanges.

The development was first reported by The Information, which said the proposal remains in its early stages and would apply only to regulated digital asset platforms. If adopted, the framework could make US equities accessible to a broader group of traders and extend availability beyond traditional market hours.

Interest in tokenized securities has grown in recent months, with platforms such as Robinhood and Kraken introducing tokenized stock products. Meanwhile, the Nasdaq exchange has filed for an SEC rule change that would permit tokenized securities to be listed on its platform. Coinbase is also reportedly seeking SEC approval to offer similar products.

Source: Nate GeraciQatari bank adopts JPMorgans blockchain platform

Qatar National Bank Group (QNB) will use JPMorgans Kinexys blockchain platform to process corporate US dollar payments more quickly and efficiently, highlighting blockchains growing role in traditional finance.

Kamel Moris, QNB‘s executive vice president of transactional banking, told Bloomberg the development is a “treasurer’s dream,” citing the platforms ability to operate around the clock. “We can guarantee payments as fast as two minutes,” Moris said.

Kinexys currently handles around $3 billion in daily transactions — a small fraction of JPMorgans $10 trillion in total daily payment flows. As Cointelegraph previously reported, Kinexys is also working with Chainlink and Ondo Finance to enable cross-chain treasury settlements.

Predictive Oncology forms DePIN-focused crypto treasury

Predictive Oncology, a Nasdaq-listed biotech company, has established a $344.4-million digital asset treasury composed entirely of Aethir (ATH) tokens, becoming the first publicly traded US firm to hold a token from a decentralized physical infrastructure network (DePIN).

The capital allocation was developed in partnership with DNA Fund, a Web3 investment and advisory firm, and supported by investment bank BTIG.

The strategy provides Predictive Oncology with exposure to the DePIN sector — blockchain networks that coordinate and incentivize the deployment of real-world infrastructure, such as compute, storage or connectivity.

Aethir operates a decentralized cloud computing network that supplies GPU infrastructure for AI and other high-performance applications. Its ATH token currently has a market capitalization of about $640 million.

“Through Aethir, ATH controls one of the largest decentralized GPU networks in the world — 435,000 GPU containers across 200-plus locations in 93 countries with direct ties into Nvidias ecosystem,” DNA Fund co-founder Chris Miglino told Cointelegraph.

ATH market cap. Source: CoinMarketCap

Crypto Biz is your weekly pulse on the business behind blockchain and crypto, delivered directly to your inbox every Thursday.

Disclaimer:

The views in this article only represent the author's personal views, and do not constitute investment advice on this platform. This platform does not guarantee the accuracy, completeness and timeliness of the information in the article, and will not be liable for any loss caused by the use of or reliance on the information in the article.

  • Crypto token price conversion
  • Exchange rate conversion
  • Calculation for foreign exchange purchasing
/
PC(S)
Current Rate
Available

0.00